Description
Seeking adults whose non-small Cell Lung Cancer has spread to other parts of their body (Metastatic) and who have not yet been treated for metastatic non-small cell lung cancer for a study of an investigational drug combination.
Overview
Participants in this study will be randomly assigned to get either investigational immunotherapy drug combination or the usual immunotherapy drug alone. The drugs are given as an IV infusion on 6-week cycles.
What we're hoping for
We are studying whether an investigational immunotherapy drug combination is better, worse or the same as the usual immunotherapy drug alone for non-small Cell Lung Cancer has spread to other parts of the body (Metastatic).
Additional Information
ClinicalTrials.gov Identifier: NCT06170788